Hróbjartsson Asbjørn, Boutron Isabelle, Hopewell Sally, Moher David, Schulz Kenneth F, Collins Gary S, Tunn Ruth, Aggarwal Rakesh, Berkwits Michael, Berlin Jesse A, Bhandari Nita, Butcher Nancy J, Campbell Marion K, Chidebe Runcie C W, Elbourne Diana R, Farmer Andrew J, Fergusson Dean A, Golub Robert M, Goodman Steven N, Hoffmann Tammy C, Ioannidis John P A, Kahan Brennan C, Knowles Rachel L, Lamb Sarah E, Lewis Steff, Loder Elizabeth, Offringa Martin, Ravaud Philippe, Richards Dawn P, Rockhold Frank W, Schriger David L, Siegfried Nandi L, Staniszewska Sophie, Taylor Rod S, Thabane Lehana, Torgerson David J, Vohra Sunita, White Ian R, Chan An-Wen
Centre for Evidence-Based Medicine Odense and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Open Patient data Explorative Network, Odense University Hospital, Odense, Denmark.
BMJ. 2025 Apr 28;389:e081660. doi: 10.1136/bmj-2024-081660.
High quality protocols facilitate proper planning, conduct, reporting, and external review of randomised trials, yet their completeness varies and key elements are often not considered. To strengthen good reporting of trial protocols, the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013 statement has been updated to incorporate new evidence and emerging perspectives. This SPIRIT 2025 explanation and elaboration document provides users with exemplars of reporting in contemporary trial protocols, contextual elaboration, more detailed guidance on reporting, references to key empirical studies, an expanded checklist, and a link to a website for further information. The document is intended to be used in conjunction with the SPIRIT 2025 statement and serves as a resource for researchers planning a trial and for others interested in trial protocols.
高质量的方案有助于随机试验的合理规划、实施、报告及外部评审,但其完整性各异,关键要素常未被纳入考量。为强化试验方案的良好报告,《标准方案条目:干预性试验建议》(SPIRIT)2013声明已更新,以纳入新证据和新观点。这份《SPIRIT 2025解释与阐述文件》为用户提供了当代试验方案报告的范例、背景阐述、更详细的报告指南、关键实证研究的参考文献、扩展清单,以及一个可获取更多信息的网站链接。该文件旨在与《SPIRIT 2025声明》一并使用,为正在规划试验的研究人员及其他对试验方案感兴趣的人提供参考资源。
PLoS Med. 2025-4-28
PLoS Med. 2025-4-28
Lancet Glob Health. 2025-4
JAMA Netw Open. 2024-4-1